meningococcal group A polysaccharide: Clinical Trials

2 trials of meningococcal group A polysaccharide, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow meningococcal group A polysaccharide: new trials by email Literature Review of meningococcal group A polysaccharide trials Research Report on meningococcal group A polysaccharide

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study on a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Compared to Two Meningococcal Reference Vaccines in European Toddlers
Meningococcal polysaccharide (serogroups A, C, Y, and W) tetanus toxoid Conjugate vaccine, Meningococcal polysaccharide group A, C, W-135 and Y Conjugate vaccine, Meningococcal group C polysaccharide Conjugate vaccine adsorbed - Meningococcal Immunisation (Healthy Volunteers)
Phase 3CompletedSanofi Pasteur, a Sanofi Company7072019-09-122025-09-15
Understanding the Immune Response to Meningitis Vaccines
Meningococcal (Groups A, C, Y and W-135) Conjugate, Meningococcal polysaccharide A, C, Y and W135 and Menveo - Meningitis, Septicemia
Phase 3CompletedUniversity of Oxford1502009-06-012014-12-05

Conditions studied

Meningitis (1)  ·  Sepsis (1)

Sponsors

Sanofi Pasteur, a Sanofi Company (1)  ·  University of Oxford (1)

Countries

Denmark (1)  ·  Finland (1)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Andrew Pollard, FRCPCH, PhD (1)

NIH funding

2018 (1)